Investigational Site Number 040001

Vienna A-1130

0 studies enrolling now · 7 studies all time

What they study most

Acute Coronary Syndrome, Diabetes Mellitus, Type 2, Fabry Disease, Hematopoietic Neoplasm, Hypercholesterolaemia

Studies at this site

• Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib — Stopped early
• Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis — Completed
• A Study of Renal Function in Treatment-naïve, Young Male Patients With Fabry Disease — Stopped early
• Efficacy and Safety of Alirocumab Versus Placebo on Top of Maximally Tolerated Lipid Lowering Therapy in Patients With Hypercholesterolemia Who Have Type 1 or Type 2 Diabetes and Are Treated With Insulin (ODYSSEY DM - Insulin) — Completed
• Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide) — Completed
• Effect of Otamixaban Versus Unfractionated Heparin + Eptifibatide in Patients With Unstable Angina/Non ST Elevation Myocardial Infarction Undergoing Early Invasive Strategy — Completed
• Efficacy Assessment of Insulin Glargine Versus LiraglutidE After Oral Agents Failure — Completed